TRAIN-BW: Backward Walking Training in Multiple Sclerosis
TRAIN-BW
1 other identifier
interventional
90
1 country
1
Brief Summary
Individuals with multiple sclerosis (MS) experience in impairments in mobility and cognition that increase the risk for accidental falls. More than 50% of individuals with MS experience injurious falls within a 6-month period. Current interventions to improve fall risk have focused on forward walking (FW) and balance training, resulting in small declines in the relative risk for falls with a large degree of variability. Interestingly, motor differences between MS and healthy controls are more pronounced in backward walking (BW), yet no studies have investigated BW training as an intervention to reduce fall risk in persons with MS. This study will investigate the feasibility, acceptability and impact of BW training compared to forward walking training on motor function and fall risk in persons with MS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable multiple-sclerosis
Started Jan 2020
Longer than P75 for not_applicable multiple-sclerosis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2019
CompletedFirst Posted
Study publicly available on registry
September 16, 2019
CompletedStudy Start
First participant enrolled
January 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2026
CompletedDecember 15, 2025
December 1, 2025
6.2 years
September 11, 2019
December 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Sway during quiet stance
Measured with APDM Sensors
Change in sway at 8 weeks
Stepping latency on push-and-release test
Measured with APDM Sensors
Change in stepping latency at 8 weeks
Secondary Outcomes (6)
Client Satisfaction Questionnaire (CSQ-8)
8 weeks
Patient Global Impression of Change
8 weeks
Number of Active Minutes
Change in Physical Activity measures at 8 weeks
Number of Falls
6 months
Forward and Backward Velocity and Double Support Time
Change in velocity and double support time at 8 weeks
- +1 more secondary outcomes
Study Arms (2)
TRAIN-BW
EXPERIMENTAL1x/week for 8 weeks + home exercise program
TRAIN-FW
ACTIVE COMPARATOR1x/week for 8 weeks + home exercise program
Interventions
Training will consist of FW training on both treadmill and overground. All participants will receive 1x/week training with a trained member of the research team, who will progress the participant week-to-week and ensure safety. Treadmill speed will be determined by baseline FW walking speed and incrementally increased with each training week to subject tolerance. Participants will follow a home exercise program for the remainder of the week that includes FW, forward stepping, and functional exercises that incorporate FW movements.
Training will consist of BW training on both a treadmill and overground. All participants will receive 1x/week training with a trained member of the research team, who will progress the participant week-to-week and ensure safety. Treadmill speed will be determined by baseline BW walking speed and incrementally increased with each training week to subject tolerance. Participants will follow a home exercise program for the remainder of the week that includes BW, backward stepping, and functional exercises that incorporate BW movements.
Eligibility Criteria
You may qualify if:
- Diagnosis of MS
- PDDS \<6, indicating ability to ambulate with or without an assistive device \>/= 50% of the time
- Self-reported walking dysfunction as evidenced by a score of \>/= 30 on MSWS-12 OR reports of 2 or more falls in the prior 6 months, indicating a frequent faller.
You may not qualify if:
- MS relapse within the past 30 days
- comorbid neurological disorder
- acute orthopedic disorder/injury
- unable to follow study-related commands
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wayne State University
Detroit, Michigan, 48201, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nora Fritz, PhD
Wayne State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 11, 2019
First Posted
September 16, 2019
Study Start
January 1, 2020
Primary Completion
February 28, 2026
Study Completion
February 28, 2026
Last Updated
December 15, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share